Sign inJoin waitlistJoin the waitlist

Russell Pachynski

Physician · Washington University School of Medicine

Credentials: · · · ·

History

Washington University School of Medicine
Present

Stanford University Medical Centner
2006–2008
Internal Medicine
Stanford University Medical Center
2003–2006
University of Wisconsin School of Medicine and Public Health
1999–2003

Research

Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial
Cancer Cell · 2020 · 331 citations
Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2
Human Gene Therapy · 2002 · 237 citations
Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance
Immunity · 2012 · 233 citations

MR
Melissa Reimers
13 papers · 1 as a fellow
Aadel Chaudhuri
7 papers · 7 as a resident
Eric Kim
7 papers · 2 as a fellow
Eugene Butcher
6 papers
Jeff Michalski
6 papers
JP
Joel Picus
6 papers
Joseph Ippolito
6 papers
UV
Ulka Vaishampayan
6 papers
BB
Brian Baumann
5 papers
Cody Weimholt
5 papers
Daniel Petrylak
5 papers
Eric Knoche
5 papers

Grants

Human Prostate Tumor Atlas Center
National Cancer Institute · U01
PI · $5.3M · Washington University
2024–2029
Novel ctDNA Biomarker for Androgen Therapy in Metastatic Prostate Cancer
National Cancer Institute · R01
PI · $1.8M · Washington University
2023–2028

Clinical trials

Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate Cancer
Principal investigator · Not yet recruiting · Phase 1
Washington University School of Medicine
2026–2031
Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)
Principal investigator · Completed · Phase 1
Washington University School of Medicine
2021–2025
Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy
Principal investigator · Suspended · Phase 1, Phase 2
National Cancer Institute (NCI)
2020–2027
Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer
Principal investigator · Completed · Phase 1
Washington University School of Medicine
2018–2022